$GTCH SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE)
Post# of 7617
(Total Views: 148)
Posted On: 03/31/2022 10:42:05 AM
$GTCH SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is concluding its qTerm vitals device with temperature measurement enhanced algorithms, with the goal further improving its accuracy and feedback. The code enhancements were made within high system’s level to advance the finger, device, and ambient temperature interactions and reporting. Testing was conducted to finalize qTerm GEN III prototype device and based on the collected data, GBT has finalized the device’s functionality and features. qTerm, a human vitals intelligent device is targeted to measure human vitals with a touch of a finger. The device includes sensors for oxygen (SPO2), heart rate and IR (Infra-Red) type for body temperature, including a coprocessor microchip that provides advanced calibration algorithm to assist users with qTerm’s usage. The device is accompanied by a smartphone app and a synchronized web widget to keep a history and provide health analytics. The widget enables the user to view qTerm’s results worldwide, making it an efficient remote telemedicine technology. The device is planned to use GBT’s AI technology for ongoing vitals’ data recordation, analytics, and health monitoring. In case of abnormalities the system will alert, advising further health related steps. The system will be offering API (Application Programming Interface) capabilities to be connected to hospitals and clinics health system, enabling health professional to view patient’s history and analytics. GEN III prototype has gone through enclosure, circuit, and software modifications to attain a stable and accurate results, targeting personal and clinics usage.
https://www.nasdaq.com/press-release/gbt-is-c...algorithms
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
